Statistics

Total Visits

Views
Long-term responders to first-line bevacizumab-based therapy among patients (pts) with HER2-negative metastatic breast cancer (MBC): Retrospective results of an ambispective observational study91

Select a period of time:

Number of views in the range

Views
Long-term responders to first-line bevacizumab-based therapy among patients (pts) with HER2-negative metastatic breast cancer (MBC): Retrospective results of an ambispective observational study23

Views

Views
October 20255
November 202514
December 20251
January 20261
February 20260
March 20261
April 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States6
Spain3
Brazil3
United Kingdom2
Iran2
Argentina2
Colombia1
Honduras1
Morocco1
Pakistan1
 

Top cities views

Views
Madrid2
Cereté1
Itapetininga1
Lahore1
Los Angeles1
Posadas1
Serra1
São João da Boa Vista1
Tangier1
Villa Ballester1